170 related articles for article (PubMed ID: 28699738)
1. A Molecular Combination of Zinc(II) Phthalocyanine and Tamoxifen Derivative for Dual Targeting Photodynamic Therapy and Hormone Therapy.
Zhang FL; Song MR; Yuan GK; Ye HN; Tian Y; Huang MD; Xue JP; Zhang ZH; Liu JY
J Med Chem; 2017 Aug; 60(15):6693-6703. PubMed ID: 28699738
[TBL] [Abstract][Full Text] [Related]
2. A zinc(II) phthalocyanine conjugated with an oxaliplatin derivative for dual chemo- and photodynamic therapy.
Lau JT; Lo PC; Fong WP; Ng DK
J Med Chem; 2012 Jun; 55(11):5446-54. PubMed ID: 22646131
[TBL] [Abstract][Full Text] [Related]
3. Fully protected glycosylated zinc (II) phthalocyanine shows high uptake and photodynamic cytotoxicity in MCF-7 cancer cells.
Kimani SG; Shmigol TA; Hammond S; Phillips JB; Bruce JI; MacRobert AJ; Malakhov MV; Golding JP
Photochem Photobiol; 2013; 89(1):139-49. PubMed ID: 22803957
[TBL] [Abstract][Full Text] [Related]
4. An estrogen receptor targeted ruthenium complex as a two-photon photodynamic therapy agent for breast cancer cells.
Zhao X; Li M; Sun W; Fan J; Du J; Peng X
Chem Commun (Camb); 2018 Jun; 54(51):7038-7041. PubMed ID: 29873358
[TBL] [Abstract][Full Text] [Related]
5. Preparation and In Vitro Photodynamic Activity of Glucosylated Zinc(II) Phthalocyanines as Underlying Targeting Photosensitizers.
Liu JY; Wang C; Zhu CH; Zhang ZH; Xue JP
Molecules; 2017 May; 22(5):. PubMed ID: 28534823
[TBL] [Abstract][Full Text] [Related]
6. A novel strategy for targeting photodynamic therapy. Molecular combo of photodynamic agent zinc(II) phthalocyanine and small molecule target-based anticancer drug erlotinib.
Zhang FL; Huang Q; Zheng K; Li J; Liu JY; Xue JP
Chem Commun (Camb); 2013 Oct; 49(83):9570-2. PubMed ID: 24018863
[TBL] [Abstract][Full Text] [Related]
7. Multifunctionalized biocatalytic P22 nanoreactor for combinatory treatment of ER+ breast cancer.
Chauhan K; Hernandez-Meza JM; Rodríguez-Hernández AG; Juarez-Moreno K; Sengar P; Vazquez-Duhalt R
J Nanobiotechnology; 2018 Feb; 16(1):17. PubMed ID: 29463260
[TBL] [Abstract][Full Text] [Related]
8. Receptor-targeting phthalocyanine photosensitizer for improving antitumor photocytotoxicity.
Xu P; Chen J; Chen Z; Zhou S; Hu P; Chen X; Huang M
PLoS One; 2012; 7(5):e37051. PubMed ID: 22693566
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and in vitro photodynamic activities of di-alpha-substituted zinc(ii) phthalocyanine derivatives.
Liu JY; Lo PC; Jiang XJ; Fong WP; Ng DK
Dalton Trans; 2009 Jun; (21):4129-35. PubMed ID: 19452061
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and in vitro anticancer activity of zinc(II) phthalocyanines conjugated with coumarin derivatives for dual photodynamic and chemotherapy.
Zhou XQ; Meng LB; Huang Q; Li J; Zheng K; Zhang FL; Liu JY; Xue JP
ChemMedChem; 2015 Feb; 10(2):304-11. PubMed ID: 25369981
[TBL] [Abstract][Full Text] [Related]
11. A phthalocyanine-peptide conjugate with high in vitro photodynamic activity and enhanced in vivo tumor-retention property.
Ke MR; Yeung SL; Fong WP; Ng DK; Lo PC
Chemistry; 2012 Apr; 18(14):4225-33. PubMed ID: 22378352
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and comparative photodynamic properties of two isosteric alkyl substituted zinc(II) phthalocyanines.
Gauna GA; Marino J; García Vior MC; Roguin LP; Awruch J
Eur J Med Chem; 2011 Nov; 46(11):5532-9. PubMed ID: 21955680
[TBL] [Abstract][Full Text] [Related]
13. In vitro photodynamic activities of zinc(II) phthalocyanines substituted with pyridine moieties.
Liu JY; Li J; Yuan X; Wang WM; Xue JP
Photodiagnosis Photodyn Ther; 2016 Mar; 13():341-343. PubMed ID: 26192694
[No Abstract] [Full Text] [Related]
14. Targeting of the photocytotoxic compound AlPcS4 to Hela cells by transferrin conjugated PEG-liposomes.
Gijsens A; Derycke A; Missiaen L; De Vos D; Huwyler J; Eberle A; de Witte P
Int J Cancer; 2002 Sep; 101(1):78-85. PubMed ID: 12209592
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic cell-kill analysis of breast tumor cells with a tamoxifen-pyropheophorbide conjugate.
Fernandez Gacio A; Fernandez-Marcos C; Swamy N; Dunn D; Ray R
J Cell Biochem; 2006 Oct; 99(3):665-70. PubMed ID: 16795032
[TBL] [Abstract][Full Text] [Related]
16. Targeting gastrin-releasing peptide receptors of prostate cancer cells for photodynamic therapy with a phthalocyanine-bombesin conjugate.
Dubuc C; Langlois R; Bénard F; Cauchon N; Klarskov K; Tone P; van Lier JE
Bioorg Med Chem Lett; 2008 Apr; 18(7):2424-7. PubMed ID: 18329268
[TBL] [Abstract][Full Text] [Related]
17. A tumor-targeted Ganetespib-zinc phthalocyanine conjugate for synergistic chemo-photodynamic therapy.
Huang L; Wei G; Sun X; Jiang Y; Huang Z; Huang Y; Shen Y; Xu X; Liao Y; Zhao C
Eur J Med Chem; 2018 May; 151():294-303. PubMed ID: 29627724
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and in vitro photodynamic activities of an integrin-targeting cRGD-conjugated zinc(II) phthalocyanine.
Ke MR; Ng DK; Lo PC
Chem Asian J; 2014 Feb; 9(2):554-61. PubMed ID: 24203795
[TBL] [Abstract][Full Text] [Related]
19. Lenvatinib-zinc phthalocyanine conjugates as potential agents for enhancing synergistic therapy of multidrug-resistant cancer by glutathione depletion.
Wei G; Huang L; Jiang Y; Shen Y; Huang Z; Huang Y; Sun X; Zhao C
Eur J Med Chem; 2019 May; 169():53-64. PubMed ID: 30856406
[TBL] [Abstract][Full Text] [Related]
20. Novel theranostic zinc phthalocyanine-phospholipid complex self-assembled nanoparticles for imaging-guided targeted photodynamic treatment with controllable ROS production and shape-assisted enhanced cellular uptake.
Ma J; Li Y; Liu G; Li A; Chen Y; Zhou X; Chen D; Hou Z; Zhu X
Colloids Surf B Biointerfaces; 2018 Feb; 162():76-89. PubMed ID: 29154189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
